🇺🇸 FDA
Patent

US 7098306

Method and compositions for treating hepatocellular cancer

granted A61KA61K2039/5158A61K2039/5256

Quick answer

US patent 7098306 (Method and compositions for treating hepatocellular cancer) held by The Regents of the University of California expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/5158, A61K2039/5256, A61K2039/55566, A61K2239/31